user
menu
letter
Sign InRegister
langEnglisharrow

CCR8

CCR8

CCR8 Overview

Molecule Name
C-C chemokine receptor type 8
Synonyms
CC chemokine receptor 8,CDw198,ChemR1,CKRL1,CKR-L1,CKRL1,CY6,GPRCL1,GPRCY6,GPR-CY6,TER-1
Drug Development Progress
Drugs in Clinical Trials21
Approved Drugs0
Highest Development StagePhase 3 Clinical
Target Synonym
Chemokine (C-C) Receptor 8，CC Chemokine Receptor 8，CDw198 Antigen，C-C CKR-8，CC-CKR-8，CCR-8，CMKBRL2，C-C Motif Chemokine Receptor 8，CC chemokine receptor CHEMR1，C-C chemokine receptor type 8，Chemokine (C-C Motif) Receptor 8，C-C Chemokine Receptor Type 8，CC Chemokine Receptor CHEMR1，Chemokine Receptor-Like 1，Chemokine (C-C) Receptor-Like 2，CC-Chemokine Receptor Chemr1，CD_antigen=CDw198，Chemokine receptor-like 1，CKRL1，CKR-L1，CMKBR8，GPRCY6，GPR-CY6，TER1，CDw198，CY6
Background
CCR8 is a G protein-coupled chemokine receptor expressed on regulatory T cells and in tumor microenvironments, mediating chemotaxis, immune regulation, and pathological processes like inflammation or cancer progression. The unconjugated anti-human CCR8 antibody enables specific detection of human CCR8.

CCR8 Product List

Species
  • Human（6）
  • Mouse（1）
  • Rhesus macaque（1）
Tag
  • -（5）
  • His Tag & Flag Tag & Strep Tag（2）
  • His Tag & Flag Tag（1）
Host
  • HEK293（8）
Conjugate
  • Unconjugated（6）
  • Biotin-labeled（2）
Grade
  • RUO（8）
Low Endotoxin
  • No（8）
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&Price
CCR8
HOTAIDD‑Ready
CC8-H52D7
Human CCR8 Protein, Flag,His Tag&Twin-Strep Tag (Nanodisc)
Human
HEK293
ELISA

$1440.00

20ug
CCR8
HOTAIDD‑Ready
CC8-H52D6
Human CCR8 Protein, Flag,His Tag&Twin-Strep Tag (Detergent)
Human
HEK293
ELISASPR

$805.00

20ug
CCR8
AIDD‑Ready
CC8-H52D3
Human CCR8 Full Length Protein, Flag,His Tag (Nanodisc-pro)
Human
HEK293
ELISA

$750.00

20ug
CCR8
AIDD‑Ready
CC8-H52P5
Human CCR8 Protein (VLP)
Human
HEK293
HPLC
ELISAIdentity

$620.00

20ug
CCR8
AvitagAIDD‑Ready
CC8-H82D3
Biotinylated Human CCR8 Protein, His,Flag Tag&Avitag™ (Detergent)
Human
HEK293
ELISASPR

$1240.00

20ug
CCR8
AvitagAIDD‑Ready
CC8-H82D4
Biotinylated Human CCR8 Protein, His,Flag&Avitag™ (Nanodisc)
Human
HEK293
ELISASPR

$1955.00

20ug
CCR8
AIDD‑Ready
CC8-M52P3
Mouse CCR8 Full Length Protein (VLP)
Mouse
HEK293
Identity

$620.00

20ug
CCR8
AIDD‑Ready
CC8-R52P3
Rhesus macaque CCR8 Full Length Protein (VLP)
Rhesus macaque
HEK293
ELISAIdentity

$620.00

20ug
You Have Viewed 1-8 Of 8 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Product InquiryRequest Customization
Asset Licensing Opportunity

Antibody Project Trading Platform

Project NameProject StageMolecule TypeMolecule SourceDisease AreaIndication
CCR8 mAb - 01PCCMonoclonalHumanized MouseSolid TumorSolid tumor
CCR8 mAb - 02LeadMonoclonalHumanized MouseSolid TumorSolid tumor
CCR8 mAb - 03PCCMonoclonalHumanized MouseSolid TumorSolid tumor
Project Name
CCR8 mAb - 01
Project Stage
PCC
Molecule Type
Monoclonal
Molecule Source
Humanized Mouse
Disease Area
Solid Tumor
Indication
Solid tumor
Project Name
CCR8 mAb - 02
Project Stage
Lead
Molecule Type
Monoclonal
Molecule Source
Humanized Mouse
Disease Area
Solid Tumor
Indication
Solid tumor
Project Name
CCR8 mAb - 03
Project Stage
PCC
Molecule Type
Monoclonal
Molecule Source
Humanized Mouse
Disease Area
Solid Tumor
Indication
Solid tumor

Project Cooperation

Project NameDrug TypeTherapeutic AreaIndicationStageRights Area
CCR8 Humanized AntibodyBispecific antibodyOncology/CancerSolid TumorPreclinicalGlobal
Project Name
CCR8 Humanized Antibody
Drug Type
Bispecific antibody
Therapeutic Area
Oncology/Cancer
Indication
Solid Tumor
Stage
Preclinical
Rights Area
Global
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
CafelkibartLM-108Phase 3 ClinicalLaNova Medicines Ltd
Carcinoma, Non-Small-Cell Lung; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms
Details
ImzokitugBMS-986340; ONO-7427Phase 2 ClinicalEeig Bristol-Myers Squibb Manufacturing Company Bristol-Myers Squibb Srl
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Esophageal Neoplasms; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms
Details
TAK- 188TAK- 188Phase 2 ClinicalTakeda Pharmaceutical Co Ltd
Solid tumours
Details
QLP2117QLP2117; QLP-2117Phase 2 ClinicalQilu Pharmaceutical Co Ltd
Neoplasms; Solid tumours
Details
DT-7012DT-7012Phase 2 ClinicalDomain Therapeutics SA
Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Neoplasms; Sezary Syndrome; Solid tumours
Details
S-531011S-531011Phase 2 ClinicalShionogi Inc
Solid tumours
Details
IPG-7236IPG-7236Phase 2 ClinicalNanjing Immunophage Biotech Co Ltd
Breast Neoplasms; Dermatitis, Atopic; Solid tumours
Details
anti-CCR8 antibody (Bristol-Myers Squibb)Phase 1 ClinicalBristol-Myers Squibb Company
Solid tumours
Details
PSB-114PSB-114Phase 1 ClinicalQilu Puget Sound Biotherapeutics Corp
Neoplasms
Details
BAY-3375968BAY-3375968Phase 1 ClinicalBayer AG
Neoplasms; Solid tumours
Details
ICP-B05ICPB05; CM-369Phase 1 ClinicalInnoCare Pharma Ltd, Keymed Biosciences Co Ltd
Hematologic Neoplasms; Solid tumours
Details
HBM-1022HBM-1022Phase 1 ClinicalHarbour Biomed
Neoplasms
Details
DenikitugJTX-1811; GS-1811Phase 1 ClinicalJounce Therapeutics Inc
Solid tumours
Details
TagmokitugCHS-114; SRF-114Phase 1 ClinicalSurface Oncology Inc
Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
TQB-6457TQB-6457; TQB6457Phase 1 ClinicalShanghai Chia Tai Tianqing Pharmaceutical Technology Development Co Ltd
Neoplasms
Details
KYS-2301KYS2301; KYS-2301Phase 1 ClinicalJiangsu Kanion Pharmaceutical Co Ltd
Dermatitis, Atopic
Details
AMG-355AMG 355; AMG-355Phase 1 ClinicalAmgen Inc
Solid tumours
Details
HC-006HC-006; HC006Phase 1 ClinicalShanghai Hongcheng Pharmaceutical Co Ltd
Neoplasms; Solid tumours
Details
BGB-A3055BGB-A3055Phase 1 ClinicalBeOne Medicines Ltd
Solid tumours
Details
ABBV-514ABBV-514Phase 1 ClinicalAbbvie Inc
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Cystadenocarcinoma, Serous; Ovarian Neoplasms; Pancreatic Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
Details
IPGA-05IPGA-05; IPG0521; IPG-0521Phase 1 ClinicalNanjing Immunophage Biotech Co Ltd
Autoimmune Diseases; Immunoglobulin G4-Related Disease; Solid tumours
Details
Customer Reviews